NYSE - Delayed Quote USD
Alto Neuroscience, Inc. (ANRO)
2.6400
+0.1000
+(3.94%)
At close: 4:00:02 PM EDT
2.5900
-0.05
(-1.89%)
After hours: 5:25:20 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-52,997
-47,424
-33,448
-20,394
-9,262
Investing Cash Flow
-1,875
-2,075
-470
-732
-680
Financing Cash Flow
10,259
135,691
68,130
43,789
31,688
End Cash Position
161,282
168,729
82,548
48,344
25,705
Interest Paid Supplemental Data
1,062
999
912
0
--
Capital Expenditure
-1,875
-2,075
-470
-732
-680
Issuance of Capital Stock
0
137,579
70,000
34,305
31,893
Issuance of Debt
--
--
0
9,825
0
Free Cash Flow
-54,872
-49,499
-33,918
-21,126
-9,942
12/31/2021 - 2/2/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TIL Instil Bio, Inc.
37.57
+7.11%
KAPA Kairos Pharma, Ltd.
0.5440
-3.99%
TELO Telomir Pharmaceuticals, Inc.
2.0500
+3.54%
ESLA Estrella Immunopharma, Inc.
1.0400
+5.20%
CDT Conduit Pharmaceuticals Inc.
2.4900
-3.49%
KPRX Kiora Pharmaceuticals, Inc.
3.3400
+2.77%
KYTX Kyverna Therapeutics, Inc.
3.6000
+4.35%
REVB Revelation Biosciences, Inc.
0.8396
-2.44%
CGEM Cullinan Therapeutics, Inc.
9.03
+3.08%
SLDB Solid Biosciences Inc.
4.8300
+4.55%